kras mutation and glutathion Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase glutathione biosynthesis KRAS mutant colon cancer-targeted induction
Description
(4) experiencing disturbances in mitochondrial dynamics and changes in the TCA cycle
Fulltext Views 326,791 PDF downloads 55,166
Hydroxypropyl-beta-cyclodextrins (CAS: 128446-35-5/94035-02-6) are commercially available for use as excipients, with average molar substitutions (MS) including: MS 0.62, with a molar substitution range of 0.58-0.68
doi: 10.1161/CIRCULATIONAHA.107.703389
Mitochondrial accumulation of APP and Abeta: Significance for Alzheimer disease pathogenesis
